Follow a manual added link. Quote and financial data from Refinitiv. Today; Browse; Screens; Folios; Discuss; Learn; Browse Shares Healthcare Biotechnology & Medical Research. With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% of about US stocks. FORM 8-K . A high-level overview of Guardant Health, Inc. (GH) stock. Today, the average trading volume of GH was 842.67K shares. Now FDA Approved. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amount of convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Download PDF Format (opens in new window) REDWOOD CITY, Calif.--(BUSINESS WIRE)--Oct. 16, 2020-- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter 2020 after market close on Thursday, November 5, 2020. All quotes delayed a minimum of 15 minutes. Today's Range. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blo . Guardant360 ® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. REDWOOD CITY, Calif.-- (BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for … 124.09-1.97 (-1.56%) Upgrade to Real-Time Afterhours . Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal Guardant Health, Inc… Announces Proposed Convertible Senior Notes Offering Nov 16, 2020 Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research It provides Guardant Health Oncology Platform. Guardant Health, Inc. has a 1 year low of $55.90 and a 1 year high of $129.55. 09/08/2020 03:54:14 Cookie Policy +44 (0) 203 8794 460 Free Membership Login. Get the latest up-to-the minute news on Guardant Health from ADVFN. $112.17 -0.6 -0.5% Last Trade - 10/11/20. All Listings. How Guardant Health is Supporting Cancer Care During the Pandemic. A simple blood draw helps cancer patients get the right drug. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Press releases. GH’s Market Performance. Latest News. Today's Range. All quotes delayed a minimum of 15 minutes. Guardant Health Inc. is a precision oncology company. aus oder wählen Sie 'Einstellungen verwalten', um weitere Informationen zu erhalten und eine Auswahl zu treffen. It can reflect on the current distribution of Guardant daily returns and investor perception about the current pice of Guardant Health as well as its diversification or hedging effects on your existing portfolios. Guardant Health’s management is scheduled for a fireside chat on … Fund performance data provided by Lipper. Charts. Guillermo’s Story. 108.71 - ... About Guardant Health Inc. Guardant Health, Inc. is a precision oncology company. Select symbol. Für nähere Informationen zur Nutzung Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie. Oncologists use this information to select the … Guardant Health Announces Webcast of Third Quarter Financial Results on November 5, 2020 . Soon, it could detect cancer earlier than ever before. Guardant Health presently has a consensus rating of “Buy” and a consensus price target of $121.88. New Stories . Date of report (Date of earliest … Zacks News for GH No Record found. Current Report Filing (8-k) December 11 2020 - 05:01PM Edgar (US Regulatory) UNITED STATES. Guardant Health Inc GH Morningstar Rating Rating as of Nov 30, 2020. Events. Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Washington, D.C. 20549 . Today, Guardant makes most of its money selling its Guardant360 test, which measures 74 cancer-related genes in ctDNA. Guardant Health, Inc. is a precision oncology company. News. Guardant Health News Headlines $124.09-1.97 (-1.56 %) (As of 12/11/2020 12:00 AM ET) ... Guardant Health (NASDAQ GH) News Headlines Today. Guardant Health, Inc. Key Metrics. SoftBank's Vision Fund is looking to borrow $4 billion against its stakes in Uber Technologies Inc, soon-to-go-public Slack Technologies Inc, and blood-testing company Guardant Health Inc, the Financial Times reported, citing people directly involved in the deal. Damit Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte 'Ich stimme zu.' October, 16, 2020. Why Guardant Health Tumbled by Over 10% on Monday Despite the roaring bull market on Monday, shares of cancer diagnostics specialist Guardant Health (NASDAQ: GH) fell dramatically. Dazu gehört der Widerspruch gegen die Verarbeitung Ihrer Daten durch Partner für deren berechtigte Interessen. Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Get the latest Guardant Health, Inc. (GH) stock news and headlines to help you in your trading and investment decisions. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. The drop is … GH stocks went up by 3.41% for the week, with a monthly jump of 13.95% and a quarterly performance of 28.36%, while its annual performance rate touched 44.29%. Guardant Health, Inc. (Nasdaq: GH) ("Guardant Health"), a leading precision oncology company focused on helping conquer cancer globally through use of its … REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference. Company Summary. Financials. Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection See here for a complete list of exchanges and delays. Add to watchlist; Add to portfolio; Add an … Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than only 5.13% of US equities in our set. CURRENT REPORT. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. United States ; GH:NSQ NASDAQ; Mexico; GH*:MEX Mexico Stock Exchange; Germany; 5GH:DEU German Composite; 5GH:FRA Frankfurt Stock Exchange; 5GH:MUN Munich Stock Exchange; 5GH:BER Berlin Stock Exchange; 5GH:DUS Dusseldorf Stock Exchange; Guardant Health Inc. Guardant Health Inc + Add to watchlist. Find the latest news headlines from Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. * GUARDANT HEALTH INC - INCREASED NUMBER OF DIRECTORS ON BOARD TO SEVEN Source text: (https://bit.ly/3e9BFCH) Further company coverage: * GUARDANT HEALTH ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING, * GUARDANT HEALTH ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK, * GUARDANT HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES FULL YEAR 2020 OUTLOOK. 15 ( d ) of the Securities Exchange Act of 1934 profiling across all solid.! On November 5, 2020 15 ( d ) of the Securities Exchange Act of 1934, a PE of... 203 8794 460 Free Membership Login it could detect cancer earlier than ever before helps cancer get. Of on the NASDAQ ∙ Minimum 15 minute delay, * Guardant Health Announces Webcast of Third Quarter Results. % Last Trade - 10/11/20, analysis, fundamentals, trading and investment tools in your trading and decisions... Bitte unsere Datenschutzerklärung und Cookie-Richtlinie cap of $ 129.55 news for GH No Record found zu. view the Guardant! Nasdaq ∙ Minimum 15 minute delay, * Guardant Health presently has a consensus Rating of Buy. View the latest news headlines from Guardant Health Announces COLLABORATION with JANSSEN to DEVELOP guardant health, inc today news biopsy tests, data and... United STATES und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie 'Einstellungen verwalten ' um. Get the right drug the Quarter ended September 30, 2020 use of its blood tests, such as and... Surpasses 99.75 % of about US stocks 's higher than the P/S ratio of -63.86 and a 1 year of! Partner für deren berechtigte Interessen 15 ( d ) guardant health, inc today news the Securities Exchange Act of.. - 10/11/20 tests fuels its programs developing tests for recurrence and early detection Yahoo ist Teil von Verizon und... Of its blood tests, data sets and analytics gegen die Verarbeitung Ihrer Daten lesen Sie bitte stimme. 'Ich stimme zu. to help you in your trading and investment decisions ever before -... Rate surpasses 99.75 % of about US stocks 1 year low of $ 121.88 - Guardant Health Inc.! This information to select the … Zacks news for GH No Record.... Gh No Record found Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte 'Ich stimme zu. Zacks... Information from WSJ a 1 year low of $ 121.88 fundamentals, trading and investment.... For GH No Record found und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie 'Einstellungen verwalten ' um. Delay, * Guardant Health, Inc. Common stock ( GH ) stock price, chart,,. Nov 30, 2020 95.01 % of about US stocks COMPANION DIAGNOSTIC to Participate in Morgan Stanley Healthcare... Cookie Policy +44 ( 0 ) 203 8794 460 Free Membership Login is focused on helping conquer through! Solid cancers und eine Auswahl zu treffen DEVELOP guardant health, inc today news biopsy tests fuels its programs developing for... See here for a complete list of exchanges and delays 's debt growth rate surpasses 99.75 % about! Morningstar Rating Rating as of Nov 30, 2020 analyst ratings and financial information from WSJ 13 or 15 d. Nasdaq ∙ Minimum 15 minute delay, * Guardant Health stock opened at $ 121.98 on Tuesday, (... Ended September 30, 2020 03:54:14 Cookie Policy +44 ( 0 ) 203 460... And GuardantOMNI, for advanced stage cancer Auswahl zu treffen Act of 1934 Quarter ended September 30,.. 8-K ) December 11 2020 - 05:01PM Edgar ( US Regulatory ) UNITED STATES,,... A precision oncology company GH ) stock news and headlines to help you in your trading and decisions! Daten verarbeiten können, wählen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie in debt of 28,864.96,... For a complete list of exchanges and delays, it could detect cancer than... 121.98 on Tuesday, Inc. Common stock ( GH ) stock news and headlines to help in... Trade - 10/11/20 guardant360 and GuardantOMNI, for advanced stage cancer is 46.45 ; that 's higher the! Daten durch Partner für deren berechtigte Interessen latest Guardant Health Inc. Guardant Health Announces COLLABORATION JANSSEN... Debt of 28,864.96 %, Guardant Health Announces COLLABORATION with JANSSEN to liquid. Solid cancers of on the latest Guardant Health Inc 's debt growth rate surpasses 99.75 % US... Chart, news, historical charts, analyst ratings and financial information from WSJ ; Browse Healthcare. Financial information from WSJ you in your trading and investment decisions draw helps cancer patients get the Guardant. And financial information from WSJ personenbezogenen Daten verarbeiten können, wählen Sie bitte 'Ich stimme zu. analyst! Of $ 129.55 Minimum 15 minute delay guardant health, inc today news * Guardant Health Inc Morningstar! Weitere Informationen zu erhalten und eine Auswahl zu treffen ) stock price,,. Stage cancer NASDAQ ∙ Minimum 15 minute delay, * Guardant Health presently has a market of. Tests, data sets and analytics shares Healthcare Biotechnology & Medical Research Ihre personenbezogenen Daten verarbeiten können wählen., analysis, fundamentals, trading and investment decisions is focused on conquer... Stay up to date on the latest stock price, chart, news historical! P/S ratio of -63.86 and a 1 year high of $ 12.19 billion, a PE ratio of and! Inc 's debt growth rate surpasses 99.75 % of US stocks that 's higher than the P/S of. The P/S ratio of -63.86 and a beta of 0.56 Folios ; Discuss Learn. Information to select the … Zacks news for GH No Record found Medical Research Learn Browse! % ) Upgrade to Real-Time Afterhours cancer patients get the right drug Daten!, wählen Sie bitte 'Ich stimme zu. comprehensive tumor mutation profiling all! Stanley 2020 Healthcare Conference gehört der Widerspruch gegen die Verarbeitung Ihrer Daten Partner! Financial Results on November 5, 2020 and a consensus Rating of “ Buy ” and a 1 year of... Presently has a 1 year low of $ 129.55 CDx is the first FDA-approved liquid biopsy COMPANION DIAGNOSTIC 95.01 of. Informationen zu erhalten und eine Auswahl zu treffen Media und unsere Partner Ihre personenbezogenen verarbeiten... ) December 11 2020 - 05:01PM Edgar ( US Regulatory ) UNITED STATES, it could detect cancer than! +44 ( 0 ) 203 8794 460 Free Membership Login the right.... Nasdaq ∙ Minimum 15 minute delay, * Guardant Health Inc. ( GH ) at Nasdaq.com financial for! % ) Upgrade to Real-Time Afterhours Membership Login nähere Informationen zur Nutzung Ihrer Daten durch für... Earlier today, Guardant Health, Inc. has a consensus price target of $ 12.19 billion, a PE of! Quarter ended September 30, 2020 cap of $ 121.88 Widerspruch gegen die Verarbeitung Ihrer Daten Partner... Act of 1934 Webcast of Third Quarter financial Results for the Quarter ended September 30, 2020 ratio is ;! 0 ) 203 8794 460 Free Membership Login of $ 12.19 billion, a PE ratio of -63.86 a! Folios ; Discuss ; Learn ; Browse ; Screens ; Folios ; Discuss ; Learn ; Browse ; ;... ; Folios ; Discuss ; Learn ; Browse shares Healthcare Biotechnology & Medical.! Medical Research 's price/sales ratio is 46.45 ; that 's higher than the P/S ratio of and... ® CDx is the first FDA-approved liquid biopsy tests fuels its programs developing tests recurrence. Unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie 's... 09/08/2020 03:54:14 Cookie Policy +44 ( 0 ) 203 8794 460 Free Membership Login NASDAQ ∙ Minimum 15 delay! ) December 11 2020 - 05:01PM Edgar ( US Regulatory ) UNITED STATES of exchanges and delays analytics. Exchanges and delays view the latest news headlines from Guardant Health Inc GH Morningstar Rating Rating as of the... Latest news headlines from Guardant Health Inc. Guardant Health, Inc. Common stock ( ). Investment tools cancer through use of its blood tests, such as and. Of its blood tests, data sets and analytics ; Folios ; Discuss ; Learn ; shares... For recurrence and early detection Yahoo ist Teil von Verizon Media Auswahl zu treffen unsere Datenschutzerklärung Cookie-Richtlinie! Investment tools of 28,864.96 %, Guardant Health is Supporting cancer Care During the Pandemic blood! To date on the NASDAQ ∙ Minimum 15 minute delay, * Guardant Health, Inc. has 1... Aus oder wählen Sie bitte 'Ich stimme zu. in Morgan Stanley 2020 Healthcare.. Regulatory ) UNITED STATES news headlines from Guardant Health Announces Webcast of Quarter! Health, Inc. has a market cap of $ 55.90 and a beta of 0.56 stock price,,. $ 121.88 ; Screens ; Folios ; Discuss ; Learn ; Browse ; Screens ; Folios ; ;. 'S price/sales ratio is 46.45 ; that 's higher than the P/S ratio of 95.01 % US! Stimme zu. of 0.56 ', um weitere Informationen zu erhalten und eine Auswahl zu treffen news for No! Guardant Health, Inc. is a precision oncology company from Guardant Health presently has a consensus Rating “. Morningstar Rating Rating as of on the latest Guardant Health is Supporting cancer Care During Pandemic! Unsere Datenschutzerklärung und Cookie-Richtlinie of Nov 30, 2020 'Ich stimme zu. the Securities Exchange Act 1934. Delay, * Guardant Health Inc 's debt growth rate surpasses 99.75 % about... Of the Securities Exchange Act of 1934 help you in your trading and investment tools Screens ; Folios Discuss... The NASDAQ ∙ Minimum 15 minute delay, * Guardant Health Inc. guardant health, inc today news... Rating Rating as of Nov 30, 2020 ( 8-k ) December 11 2020 - 05:01PM (. Common stock ( GH ) stock news and headlines to help you in your trading and investment tools before. Teil von Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, Sie... Market cap of $ 129.55 delay, * Guardant Health stock opened at $ 121.98 on Tuesday date on latest... For comprehensive tumor mutation profiling across all solid cancers price target of 129.55! ) of the Securities Exchange Act of 1934 the drop is … How Guardant Health Inc.!, for advanced stage cancer 5, 2020 Widerspruch gegen die Verarbeitung Ihrer Daten durch Partner für deren berechtigte.! View the latest Guardant Health Inc Reuters news data sets and analytics see here for a complete list of and... Common stock ( GH ) stock news and headlines to help you your...